Growth Metrics

BioNexus Gene Lab (BGLC) Amortizatization of Intangibles (2019 - 2025)

BioNexus Gene Lab's Amortizatization of Intangibles history spans 7 years, with the latest figure at $14768.0 for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at $14768.0 for Q4 2025, up 9.59% from a year ago — trailing twelve months through Dec 2025 was $56434.0 (up 15.21% YoY), and the annual figure for FY2025 was $56434.0, up 15.21%.
  • Amortizatization of Intangibles for Q4 2025 was $14768.0 at BioNexus Gene Lab, up from $14354.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $14807.0 in Q3 2024 to a low of $1238.0 in Q4 2022.
  • The 5-year median for Amortizatization of Intangibles is $6081.5 (2021), against an average of $8075.6.
  • The sharpest move saw Amortizatization of Intangibles tumbled 66.74% in 2022, then skyrocketed 671.41% in 2023.
  • Year by year, Amortizatization of Intangibles stood at $3722.0 in 2021, then plummeted by 66.74% to $1238.0 in 2022, then skyrocketed by 671.41% to $9550.0 in 2023, then surged by 41.11% to $13476.0 in 2024, then grew by 9.59% to $14768.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $14768.0, $14354.0, and $13933.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.